NORGES BANK - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$6,976,000
-9.6%
2,051,8990.0%0.00%
-33.3%
Q2 2018$7,715,000
-8.1%
2,051,8990.0%0.00%0.0%
Q1 2018$8,393,000
-12.0%
2,051,8990.0%0.00%0.0%
Q4 2017$9,541,000
-34.5%
2,051,8990.0%0.00%
-50.0%
Q3 2017$14,568,000
+0.5%
2,051,899
+2.3%
0.01%0.0%
Q2 2017$14,502,000
+38.3%
2,005,796
+17.9%
0.01%
+50.0%
Q1 2017$10,484,000
+5.1%
1,701,9350.0%0.00%0.0%
Q4 2016$9,973,000
+15.5%
1,701,9350.0%0.00%0.0%
Q3 2016$8,632,000
-23.4%
1,701,9350.0%0.00%
-20.0%
Q2 2016$11,267,000
+41.8%
1,701,9350.0%0.01%
+25.0%
Q1 2016$7,948,000
-13.1%
1,701,935
-6.1%
0.00%
-20.0%
Q4 2015$9,150,000
+175.9%
1,811,935
+92.4%
0.01%
+150.0%
Q3 2015$3,316,000
-64.7%
941,9350.0%0.00%
-60.0%
Q2 2015$9,401,000
+22.0%
941,935
+55.6%
0.01%
+25.0%
Q1 2015$7,708,000605,5200.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders